FDA approves inhalable diabetes drug Afrezza

June 27, 2014 11:03 PM

10 0

FDA approves inhalable diabetes drug Afrezza

The Food and Drug Administration on Friday approved a long-delayed inhalable diabetes medication to help patients control their blood sugar levels during meals.

The FDA cleared MannKind Corp.'s Afrezza, a fast-acting form of insulin, for adults with the most common form of diabetes, which affects more than 25 million Americans. The approval decision comes more than three years after the agency first asked MannKind to run additional clinical studies on the d...

Also read: Private equity firm Northstar to buy Singapore-listed Innovalues for $239 mln

Read more

To category page